InvestorsHub Logo

CrashOverride

08/27/22 8:03 PM

#508610 RE: jimmy667 #508609

Yes, it's clear for GBM that DCVax will replace SOC with the cure rate being improved further with adjuvants or neoadjuvants given in combination with DCVax.

biosectinvestor

08/27/22 8:10 PM

#508611 RE: jimmy667 #508609

Looks like it to me, and yes, with the adjuvants that seem to further increase response and improve outcomes. So it could and should be very successful IMHO.